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Abstract: To quantify the effect of a Mediterranean dietary pattern, as well as the consumption of
olive oil (OO), on the risk of having a small for gestational age infants (SGA), a matched case-control
study was conducted in Spain. Dietary intake during pregnancy was assessed using a validated
food frequency questionnaire. Three indices were used to evaluate the adherence to Mediterranean
diet (MD) (Predimed, Trichopoulou and Panagiotakos). Crude odds ratios (cOR) and adjusted
odds ratios (aOR) and their 95% confidence intervals (CI) were estimated using conditional logistic
regression models. Results were stratified by severity of SGA: moderate (percentiles 6–10), and severe
(percentiles ≤5). For moderate, four or more points in the Predimed´s index was associated with a
41% reduction of having SGA compared with women with a score ≤3, aOR = 0.59 (95% CI 0.38–0.98);
for severe, the reduction in risk was not statistically significant. Similar results were found when the
other MD indexes were used. An intake of OO above 5 g/day was associated with a lower risk of SGA
(aOR = 0.53, 95% CI 0.34–0.85); statistical significance was observed for moderate SGA (aOR = 0.53,
95% CI 0.30–0.96), but not for severe SGA (aOR = 0.51, 95% CI 0.24–1.07), although the magnitude of
ORs were quite similar. Adherence to a MD and OO intake is associated with a reduced risk of SGA.
Keywords: small for gestational age; infants; maternal nutrition; physiological phenomena;
Mediterranean diet; olive oil
1. Introduction
A newborn’s weight is considered the main determinant of perinatal morbidity and mortality [1,2],
both in the short and the long term [3,4]. The concept of small for gestational age infants (SGA)
considers birth weight, gestational age, and sex of the newborn. Restricted fetal growth is associated
with an increased risk of childhood morbidity and chronic diseases in adulthood such as respiratory
infections, diabetes mellitus, obesity, cardiovascular diseases and psychiatric disorders [5,6].
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Maternal risk factors associated with SGA can be socio-demographic variables such as age or
socioeconomic status, chronic diseases, such as diabetes or hypertension, risk factors during pregnancy,
including quality of prenatal care and maternal lifestyle risk factors [7]. Maternal nutrition is recognized
as one of the main determinants of fetal growth. The maternal diet’s composition affects the fetal
growth and determines the metabolic patterns of both mother and offspring [3,4,8–10].
Most studies published to date that evaluate diet during pregnancy have focused on the
association between individual foods or nutrients and fetal growth [11]. The foods or nutrients
associated with a lower risk of SGA are diverse depending on the study considered [12–16]. However,
nutrition is a multidimensional exposure; nutrients or foods are not consumed in isolation, and the
sources for the same nutrient can be different [17]. As such, dietary patterns may provide more useful
information than an isolated nutrient or food. Among dietary patterns, the Mediterranean diet (MD)
stands out for its effect on health, such that the American Dietary Guidelines recommends it because of
its global source of essential nutrients and its usefulness in the prevention of diseases [18]. Furthermore,
the MD can also influence the wellbeing of the mother and the fetus.
Regarding the MD and risk of SGA, the studies carried out to date are few with inconsistent
results. MD is characterized by a high consumption of olive oil (OO) as the main source of fat.
The Mediterranean dietary pattern and OO have been related to a reduction of intrauterine growth
retardation, low birth weight and premature births [9,19]. However, there are studies, which do not
include a MD pattern, that suggest that dietary patterns are not associated with the risk of SGA [20,21].
Taking into account these discrepancies, the objective of this study was to quantify the effect of the
maternal MD pattern, as well as the consumption of OO, on the risk of having a SGA infant.
2. Materials and Methods
We used a matched case-control study. The matching criterion was the maternal age at delivery
(±2 years). The study population included women who gave birth to a singleton newborn in one of
five hospitals in Eastern Andalusia (Spain): The University of Jaén Hospital (UJH), Ubeda Hospital
(UH), the University of Granada Hospitals (two centers) (UGH), and Poniente Hospital (PH), serving a
total of 1.8 million people. Case and control groups were collected between 15 May 2012 and 15 July
2015. Ethical Approval for this study was given by the Ethics Committees of the hospitals. All women
included in the study signed an informed consent.
2.1. Cases
Eligibility criteria for cases were: (1) Maternal residence in the hospital coverage area; (2) Birth of
a single live newborn; (3) Absence of congenital malformations; and (4) SGA diagnosed according to
the tables developed for the Spanish population [22]. Using neonatal growth curves (recognized by the
Spanish Society of Gynecology and Obstetrics as reference for Spanish population), neonates weighting
less than the 10th percentile, adjusted for gestational age at delivery and sex, were diagnosed as SGA;
SGA was classified as severe if percentile was ≤5 and moderate for centiles 6–10. Nineteen women
declined to participate. A total of 533 cases were selected from the four different hospitals: 79 (UJH),
46 (UH), 369 (UGH), and 39 (PH).
2.2. Controls
A match pair by maternal age at delivery (±2 years) was selected within the week following
inclusion of a case in the same hospital. Eligible women were those having a normal weight for
gestational age infants with the same selection criteria used for cases (residence in the referral area of
the hospital and no congenital malformations). Sixty-five women declined participation (Figure 1).
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Figure 1. Participant flowchart. Abbreviation: The University of Jaén Hospital (UJH), Ubeda Hospital 
(UH), the University of Granada Hospitals (two centers) (UGH), and Poniente Hospital (PH). 
2.3. Data Collection 
Three sources of data were used: (1) personal interviews (carried out within two days after 
delivery); (2) clinical charts; and (3) prenatal care records. Information on the following variables 
were obtained: Mother’s socio-demographic data (marital status, education level, ethnicity, 
socioeconomic class and occupation, monthly income, age at the beginning of the pregnancy and 
pre-pregnancy body mass index); obstetric history (parity and antecedent abortions, previous 
adverse perinatal outcomes); conditions during pregnancy (infections, preeclampsia, diabetes and 
other obstetric conditions); smoking during pregnancy; prescribed and over-the-counter drugs; 
prenatal care (number of visits and date of first visit); and birth weight (weight in grams in the 
delivery room). Social class were coded in five main levels (ranging from I, the highest, to V, the 
lowest) according to the classification of the Spanish Society of Epidemiology [23] which is close to 
that of the Black Report [24]. Prenatal care utilization was measured by using the Kessner index. This 
index includes information about both the timing of prenatal care initiation and prenatal care visits 
after initiation [25]. 
2.4. Dietary Assessment 
The baseline questionnaire included a semi-quantitative food frequency questionnaire (FFQ) 
with 137 items previously translated, adapted and validated in Spanish women aged 18–74 years. 
Moreover, the questionnaire included open-label questions for information about the use of dietary 
supplements during the pregnancy [26]. The final questionnaire has been previously assessed by de 
la Fuente-Arillaga et al. [27]. The FFQ was based on typical portion sizes and had nine options for 
the frequency of intake in the previous year for each food item (ranging from never or almost never 
to ≥6 times/day). A dietitian updated the nutrient data bank using the information recorded in the 
food composition tables for Spain [28,29]. Nutrient scores were computed using ad hoc computer 
software specifically developed for this purpose (frequency and nutrient composition of specified 
portion size for each food item). After computing total energy intake, 15 matched pairs were 
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2.3. Data Collection
Three sources of data were used: (1) personal interviews (carried out within two days after
delivery); (2) clinical charts; and (3) prenatal care records. Information on the following variables were
obtained: Mother’s socio-demographic data (marital status, education level, ethnicity, socioeconomic
class and occupation, monthly income, age at the beginning of the pregnancy and pre-pregnancy body
mass index); obstetric hist ry (parity and antecedent abortions, previous adverse perinatal outcomes);
conditions during pregnancy (infections, preeclampsia, diabetes and oth obstetric conditions);
smoking during pregnancy; prescribed and over-the-counter drugs; prenatal care (number of visits
and date of first visit); and birth weight (weight in grams in the delivery room). Social class were
coded in five main levels (ranging from I, the highest, to V, the lowest) according to the classification
of the Spanish Society of Epidemiology [23] which is close to that of the Black Report [24]. Prenatal
care utilization was measured by using the Kessner index. This index includes information about both
the timing of prenatal care initiation and prenatal care visits after initiation [25].
2.4. Dietary Assessment
The baseline questionnaire included a semi-quantitative food frequency questionnaire (FFQ)
with 137 items previously translate , adapted and validated i Spanish w men aged 18–74 years.
Moreover, th questionnaire included open-label questi s for information about the use of di tary
supplements du ing th pregnancy [26]. The final questionnaire has been previously assessed by de la
Fuente-Arillaga et al. [27]. The FFQ was based on typical portion sizes and had nine options for the
frequency of intake in the previous year for each food item (ranging from never or almost never to
≥6 times/day). A dietitian updated the nutrient data bank using the information recorded in the food
composition tables for Spain [28,29]. Nutrient scores were computed using ad hoc computer software
specifically developed for this purpose (frequency and nutrient composition of specified portion size
for each food item). After computing total energy intake, 15 matched pairs were excluded because of
unreliable dietary assessment (total energy intake above 4000 kcal/day), leaving 518 pairs for analysis.
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2.5. Mediterranean Diet Pattern Adherence Indexes
Three indices were used to evaluate the adherence to a MD:
1. Predimed, which was developed in Spain [30]. This index considers: Vegetables, legumes, fruit,
fish, red and processed meat, chicken or poultry, olive oil for cooking, consumption of olive oil,
butter-margarine, carbonated and/or sweetened beverages, commercial pastries, nuts and meals
with sofrito (traditional sauce of tomatoes, garlic, onion, or pepper in olive oil). The total score
ranged from 0 (minimum adherence) to 14 (maximum adherence). The index is configured by
12 questions on food consumption frequency and 2 questions on food intake habits considered
characteristic of the Spanish Mediterranean diet. Each question was scored as 0 or 1. One point
was given for using olive oil as the principal source of fat for cooking, preferring white meat over
red meat, or for consuming: (1) 4 or more tablespoons (1 tablespoon = 13.5 g) of olive oil/day
(including that used in frying, salads, meals eaten away from home, etc.); (2) 2 or more servings
of vegetables/day; (3) 3 or more pieces of fruit/day; (4) <1 serving of red meat or sausages/day;
(5) <1 serving of animal fat/day; (6) <1 cup (1 cup = 100 ml) of sugar-sweetened beverages/day;
(7) 7 or more servings of red wine/week; (8) 3 or more servings of pulses/week (some seeds
which can be cooked and eaten are called pulses, for example peas, beans, and lentils.); (9) 3 or
more servings of fish/week; (10) fewer than 2 commercial pastries/week; (11) 3 or more servings
of nuts/week; or (12) 2 or more servings/week of a dish with a traditional sauce of tomatoes,
garlic, onion, or leeks sautéed in olive oil. If the condition was not met, 0 points were recorded
for the category.
2. Mediterranean diet score, developed by Trichopoulou et al in Greece [31]. This index considers
the following food groups: Vegetables, legumes, fruit, fish, cereals, meat, dairy products,
and monounsaturated/saturated fats ratio. The median for each food group was estimated
using the control group. For consumption of each typical Mediterranean food higher than
the median of the consumption distribution in the control group, a person received 1 point;
consumption lower received zero points. For consumption of non-Mediterranean foods lower
than the median 1 point was awarded; consumption higher than the median received zero points.
The total score ranged from 0 (minimum adherence to a traditional Mediterranean dietary pattern)
to 8 (maximum adherence).
3. Dietary score, developed by Panagiotakos et al in Greece [32]. To estimate this index the following
groups of food are considered: vegetables, legumes, fruits, fish, whole grains, potatoes, olive oil,
poultry, dairy products with fat, and red meat. The total score ranged from 0 (minimum
adherence) to 55 (maximum adherence), with higher values indicating higher adherence to a
Mediterranean diet. Vegetables, legumes (e.g., peas, beans), fruits, fish, whole grains, and potatoes
were categorized on the basis of servings/month and specifically as: 0 = never; 1 point = 1–4
servings/month; 2 points = 5–8; 3 points = 9–12; 4 points = 13–18; and 5 points = ≥18
servings/month. Consumption of red meat, poultry, and full fat dairy products (e.g., milk cheese,
yogurt) was categorized as: 0 = ≥18 servings/ month; 1 point = 13–17 servings/month; 2 points
= 9–12; 3 points = 5–8; 4 points = 1–4; and 5 points = never. Consumption of olive oil was
categorized according to the number of times it was used in a week and specifically as: 0 = never;
1 = rare; 2 = ≤1 times/weekly; 3 = 2 times/weekly; 4 = 3–6 and 5 = daily.
Alcohol consumption has been excluded in all indices. Regardless of the index used, a higher
score indicates a greater adherence to MD pattern.
2.6. Statistical Analysis
Food and nutrient intakes were adjusted for total energy intake using the residuals method for
cases and controls as it is recommended by Willet et al. [33]. Energy-adjusted food or nutrient intakes
were categorized in quintiles. Crude and adjusted odds ratios (OR) and 95% CI were estimated with
conditional regression logistic models. To determine the variables to be included in the multivariate
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analysis, the procedure described by Sun et al. [34] was followed. Intermediate variables were
discarded. We ran two stepwise models, one backward and another forward, including variables
with a value of p < 0.2 [35,36]. We constructed a list of predictors of SGA identified in other studies.
Using information from stepwise models and the list of predictors, a saturated model was built, and by
using a heuristic approach, variables that did not change the coefficient of the bundles by more than
10% were discarded, in order to construct a parsimonious model retaining all important confounders.
Models were adjusted by income, smoking, previous preterm/LBW newborn, newborn’s gender,
total energy intake, and pre-pregnancy body mass index (BMI). BMI was calculated as weight (in kg)
just before pregnancy divided by height (in m) squared. Both weight and height were obtained from
medical records of the women if possible, or self-reported if not. All p values are 2-tailed. Statistical
significance was set at p < 0.05. Analyses were performed using the Stata Statistical Software version
14 (StataCorp LP, College Station, TX, USA).
3. Results
Table 1 shows the socio-demographic characteristics of the participant women, their lifestyles
during the pregnancy and the quality of prenatal care. The educational level and monthly incomes
were lower in cases than in controls. Moreover, the cases had a history of preterm deliveries or low
birth weight infants more frequently compared to controls, 12.4% vs. 5.0% respectively (p < 0.001),
and also for preeclampsia, 8.9% vs. 2.1% (p < 0.001). During the pregnancy, the mean weight gained
per week was lower in cases than in controls, 278 g (SD 121) vs. 310 g (SD 114); p < 0.001.
Table 1. Description of the study population of healthy pregnant Spanish women.
Variable Cases (n = 518)n (%)
Controls (n = 518)
n (%) p-Value
Marital status 0.036
Single 37 (7.1) 42 (8.1)
Stable couple 161 (31.1) 124 (23.9)
Married 320 (61.8) 352 (68.0)
Education level 0.084
Primary 112 (21.6) 93 (17.9)
High school, not finished 42 (8.1) 28 (5.4)
High school 185 (35.7) 190 (36.7)
University 179 (34.6) 207 (40.0)
Income (Euros/month) 0.009
<1000 146 (28.2) 145 (24.1)
1000–1999 245 (47.3) 218 (42.1)
2000–2999 99 (19.1) 129 (24.9)
≥3000 28 (5.4) 46 (8.9)
Kessner index (prenatal care) 0.737
Adequate 259 (50.0) 253 (48.8)
Intermediate 185 (35.7) 182 (35.2)
Inadequate 74 (14.3) 83 (16.0)
Smoking during pregnancy 149 (28.8) 80 (15.4) <0.001
Previous preterm/low birthweight Newborn 64 (12.4) 46 (5.0) <0.001
Weight gain during pregnancy (g/week), mean (SD) 278 (121) 310 (114) <0.001
Pre-pregnancy Body Mass Index (BMI), mean (SD) 23.1 (4.5) 23.9 (4.1) <0.001
Total energy intake (kcal/day), mean (SD) 2547 (561) 2493 (538) 0.118
Alcohol intake (g/week), mean (SD) 4.2 (18.5) 3.1 (15.2) 0.312
SD: Standard deviation.
In Table 2 the individual components of the Predimed index are analyzed. In crude analyses
only item 7 (fish) was protective for the risk of SGA, whereas in adjusted analyses no item reached
statistical significance; it was borderline for items 6 (legumes) and 7 (fish). The Predimed score was
lower for cases than for controls, 5.1 (SD 0.07) vs. 5.4 (SD 0.06); p = 0.027. The relationship between
the Predimed score with SGA is shown in Table 3. In crude analyses, a score of 4 and more decreased
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the risk, although it was not confirmed in multivariate analyses. However, SGA were stratified in
two groups: moderate (percentiles 6–10) and severe (percentiles ≤5). For moderate SGA a significant
association was observed with a score of ≥4 (aOR = 0.59, 95% CI, 0.38–0.98), not seen for severe SGA.
No trend was observed (the higher the score the lower the risk) in any case.
Table 2. Items of the PREDIMED score for adherence to Mediterranean diet and risk of Small for
Gestational Age (SGA).
Predimed Item Cases (n = 518)n (%)
Controls (n = 518)
n (%) cOR (95% CI) aOR (95% CI)
Olive oil used as the main fat for cooking 502 (96.9) 508 (98.1) 0.60 (0.26–1.37) 0.73 (0.30–1.74)
Olive oil: 4+ tablespoons a day 68 (13.3) 57 (11.0) 1.22 (0.84–1.77) 1.12 (0.75–1.68)
Vegetables: 2+ servings a day 279 (53.9) 275 (53.1) 1.03 (0.81–1.81) 1.05 (0.81–1.36)
Fruit: 3+ servings a day 78 (15.1) 95 (18.3) 0.79 (0.57–1.10) 0.86 (0.61–1.22)
Red meat/sausages: <1 a day 103 (19.9) 116 (22.4) 0.85 (0.63–1.16) 0.90 (0.65–1.27)
Butter/margarine/cream: <1 serving a day 429 (82.8) 444 (85.7) 0.81 (0.58–1.13) 0.88 (0.61–1.27)
Soft drinks (sweet, carbonated): <1 a day 247 (47.7) 262 (50.6) 0.88 (0.69–1.14) 0.92 (0.70–1.21)
Legumes: 3+ servings a week 264 (51.0) 281 (54.3) 0.88 (0.69–1.12) 0.80 (0.61–1.04)
Fish: 3+ servings a week 409 (79.0) 434 (83.8) 0.72 (0.52–0.99) * 0.75 (0.53–1.07)
Cakes and pastries (not done at home): <2 units a week 141 (27.2) 170 (32.8) 0.78 (0.60–1.01) 0.88 (0.65–1.19)
Nuts: 3+ servings a week 123 (23.8) 108 (20.9) 1.20 (0.82–1.62) 1.16 (0.83–1.61)
White meat more frequently than red meat 16 (3.1) 17 (3.3) 0.94 (0.46–1.90) 1.01 (0.47–2.21)
aOR: Adjusted odds ratio by income, smoking, weight gain per week during pregnancy, previous preterm/low
birthweight newborn, energy intake, and pre- pregnancy BMI. cOR: Crude odds ratio and confidence intervals
(95% CI). * Significant association.
Table 3. Total Predimed score and risk of SGA for the entire sample and stratified on degree of SGA.
Predimed Score Casesn (%)
Controls
n (%) cOR (95% CI) aOR (95% CI)
All SGA
(n = 518) (n = 518)
≤3 86 (16.6) 58 (11.2) 1 (reference) 1 (reference)
4 85 (16.4) 87 (16.8) 0.66 (0.43–1.04) 0.81 (0.50–1.31)
5 139 (26.8) 144 (27.8) 0.67 (0.44–0.99) * 0.75 (0.49–1.15)
6 107 (20.7) 119 (23) 0.61 (0.40–0.93) * 0.67 (0.43–1.05)
>6 101 (19.5) 110 (21.2) 0.63 (0.41–0.96) * 0.77 (0.49–1.21)
p for trend 0.152 0.482
≤3 vs. ≥4 0.65 (0.45–0.92) * 0.74 (0.51–1.08)
Moderate SGA, Percentiles 6–10
(n = 323) (n = 323)
≤3 55 (17.0) 35 (10.8) 1 (reference) 1 (reference)
4 55 (17.0) 54 (16.7) 0.66 (0.37–1.18) 0.72 (0.38–1.35)
5 80 (24.8) 95 (29.4) 0.55 (0.33–0.92) * 0.51 (0.29–0.90) *
6 76 (23.5) 75 (23.2) 0.66 (0.38–1.12) 0.61 (0.34–1.09)
>6 57 (17.7) 64 (19.8) 0.59 (0.34–1.01) 0.64 (0.35–1.17)
p for trend 0.212 0.446
≤3 vs. ≥4 0.60 (0.38–0.94) * 0.59 (0.38–0.98) *
Severe SGA, Percentiles≤5
(n = 195) (n = 195)
≤3 31 (15.9) 23 (11.8) 1 (reference) 1 (reference)
4 30 (15.4) 33 (16.9) 0.70 (0.34–1.42) 0.93 (0.43–2.02)
5 59 (30.3) 49 (25.1) 0.97 (0.50–1.87) 1.21 (0.59–2.50)
6 31 (15.9) 44 (22.6) 0.53 (0.26–1.06) 0.64 (0.31–1.35)
>6 44 (22.6) 46 (23.6) 0.70 (0.36–1.37) 0.92 (0.44–1.95)
p for trend 0.810 0.461
≤3 vs. ≥4 0.72 (0.41–1.27) 0.91 (0.49–1.68)
aOR: Adjusted odds ratio by income, smoking, previous preterm/low birthweight newborn, energy intake,
newborn’s gender, and pre-pregnancy BMI. cOR: Crude odds ratio and confidence intervals (95% CI).
* Significant association.
Table 4 shows the results for the two Greek indexes of adherence to the Mediterranean diet,
the one proposed by Trichopoulou et al. [31] and the other by Panagiotakos et al. [32] When the means
of the indexes are considered, no differences between groups are observed: For Trichopoulou score,
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4.2 (SD 0.07) for women with a SGA infants vs. 4.0 (SD 0.08) for the control group (p = 0.185); and for
Panagiotakos score, 29.2 (SD 0.17) vs. 28.75 (SD 0.17) respectively (p = 0.083). With Trichopoulou score
no trend with SGA risk was appreciated, although a score of ≥3 was associated with a lower risk
of SGA (aOR 0.58, 95% CI, 0.41–0.84). This association was evident for moderate SGA (aOR = 0.49,
95% CI, 0.71–0.79), and not for severe SGA (aOR = 0.74, 95% CI, 0.41–1.33).
With Panagiotakos score, no relationship was observed when the whole group of SGAs was
analyzed (Table 4). However, in the subgroup of moderate SGA, a score of ≥29 reduced the risk of
SGA (aOR = 0.57, 95% CI, 0.39–0.83), not observed for severe SGA (aOR = 1.54, 95% CI, 0.98–2.48).
Table 4. Trichopoulou and Panagiotakos scores and risk of SGA for entire sample and stratified on
degree of SGA.
Cases n (%) Controls n (%) cOR (95% CI) aOR (95% CI)
Trichopoulou Score
All SGA
(n = 518) (n = 518)
≤2 109 (21.0) 74 (14.3) 1 (reference) 1 (reference)
3–4 203 (39.2) 228 (44.0) 0.59 (0.41–0.85) * 0.53 (0.36–0.78) *
5–6 161 (31.1) 180 (34.8) 0.59 (0.40–0.86) * 0.59 (0.39–0.88) *
>6 45 (8.7) 36 (7.0) 0.84 (0.50–1.43) 0.92 (0.51–1.64)
p for trend 0.289 0.612
≤2 vs. ≥3 0.62 (0.42–0.86) * 0.58 (0.41–0.84) *
Moderate SGA, Percentiles 6–10
(n = 323) (n = 323)
≤2 71 (22.0) 43 (13.3) 1 (reference) 1 (reference)
3–4 135 (41.8) 143 (44.3) 0.52 (0.33–0.82) * 0.55 (0.34–0.89) *
5–6 95 (29.4) 116 (35.9) 0.43 (0.27–0.69) * 0.47 (0.28–0.78) *
>6 22 (6.8) 21 (6.5) 0.73 (0.37–1.46) 0.73 (0.35–1.52)
p for trend 0.040 0.075
≤2 vs. ≥3 0.53 (0.34–0.82) * 0.49 (0.31–0.79) *
Severe SGA, Percentiles≤5
(n = 195) (n = 195)
≤ 2 38 (19.4) 31 (15.9) 1 (reference) 1 (reference)
3–4 68 (34.9) 85 (43.6) 0.62 (0.34–1.12) 0.57 (0.29–1.10)
5–6 66 (33.9) 64 (32.8) 0.84 (0.46–1.54) 0.77 (0.40–1.51)
>6 23 (11.8) 15 (7.7) 1.23 (0.57–2.68) 1.44 (0.60–3.43)
p for trend 0.437 0.302
≤2 vs. ≥3 0.77 (0.45–1.32) 0.74 (0.41–1.33)
Panagiotakos Score
All SGA
(n = 518) (n = 518)
≤ 26 129 (24.9) 116 (22.4) 1 (reference) 1 (reference)
27–28 107 (20.7) 103 (19.9) 0.93 (0.63–1.35) 0.93 (0.62–1.45)
29–30 109 (21.0) 120 (23.2) 0.80 (0.56–1.16) 0.77 (0.51–1.15)
31–32 95 (18.3) 77 (14.9) 1.09 (0.73–1.63) 1.05 (0.67–1.65)
> 32 78 (15.1) 102 (19.7) 0.68 (0.46–1.02) 0.67 (0.43–1.05)
p for trend 0.078 0.097
≤28 vs. ≥29 0.87 (0.68–1.12) 0.84 (0.64–1.11)
Moderate SGA, Percentiles 6–10
(n = 323) (n = 323)
≤26 91 (28.2) 69 (21.4) 1 (reference) 1 (reference)
27–28 71 (22.0) 58 (18.0) 0.91 (0.56–1.48) 1.00 (0.58–1.22)
29–30 59 (18.3) 83 (25.7) 0.52 (0.32–0.84) * 0.49 (0.29–0.85) *
31–32 56 (17.3) 45 (13.9) 0.90 (0.53–1.52) 0.85 (0.46–1.57)
>32 46 (14.2) 68 (21.0) 0.48 (0.28–0.80) * 0.47 (0.26–0.86) *
p for trend 0.008 * 0.015 *
≤28 vs. ≥29 0.62 (0.45–0.87) * 0.57 (0.39–0.83) *
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Table 4. Cont.
Cases n (%) Controls n (%) cOR (95% CI) aOR (95% CI)
Severe SGA, Percentiles≤5
(n = 195) (n = 195)
≤26 38 (19.5) 47 (24.1) 1 (reference) 1 (reference)
27–28 36 (18.5) 45 (23.1) 1.00 (0.54–1.87) 0.79 (0.39–1.59)
29–30 50 (25.6) 37 (19.0) 1.63 (0.89–2.98) 1.53 (0.79–2.97)
31–32 39 (20.0) 32 (16.4) 1.52 (0.80–2.90) 1.42 (0.69–2.90)
>32 32 (16.4) 34 (17.4) 1.22 (0.64–2.33) 1.06 (0.51–2.23)
p for trend 0.610 0.770
≤28 vs. ≥29 1.33 (0.81–2.20) 1.19 (0.69–2.07)
aOR: Adjusted odds ratio by income, smoking, previous preterm/low birthweight newborn, energy intake,
newborn’s gender, and pre-pregnancy BMI; cOR: Crude odds ratio and confidence intervals (95% CI);
* Significant association.
OO is the most characteristic component of the MD. The frequency and daily intake (grams per
day) of OO and its relationship with the risk of SGA newborn is shown in Table 5. An analysis by
quintiles did not reveal any association; after examining the raw data it was observed that above
10 g/day no relationship was found, therefore we used ad hoc cutoff points. No trend was detected:
an intake above 10 g/day did not further decrease the risk appreciated with intakes of 5–9 g/day.
This protective effect is observed in moderate SGA with a significant aOR = 0.53 (95% CI, 0.30–0.96) for
an intake above 5 g/day. In severe SGA this intake did not achieve significance (aOR = 0.51, 95% CI,
0.24–1.07), being the OR figure (0.51) quite similar to that found in moderate SGA (0.53), although the
sample size is smaller. These results are for all types of OO. In our study population, extra virgin OO
was 79.8% of all OO intake. The analyses were repeated for extra virgin OO and no relevant differences
were found with those shown in Table 5.
Table 5. Daily intake (g/day) of olive oil (OO) and risk of SGA for entire sample and stratified on
degree of SGA.
OO Daily Intake (g/day) Cases n (%) Controls n (%) cOR (95% CI) aOR (95% CI)
All SGA
<5 71 (13.7) 42 (8.1) 1 (reference) 1 (reference)
5–9.9 60 (11.6) 70 (13.5) 0.48 (0.28–0.82) * 0.52 (0.29–0.93) *
10–19.9 150 (29.0) 159 (30.7) 0.53 (0.34–0.85) * 0.55 (0.33–0.89) *
20–29.9 149 (28.8) 170 (32.8) 0.49 (0.31–0.78) * 0.49 (0.30–0.81) *
≥30 88 (17.0) 77 (14.9) 0.64 (0.39–1.06) 0.61 (0.51–1.05)
p for trend 0.735 0.961
<5 vs. ≥5 0.53 (0.35–0.81) * 0.53 (0.34–0.85) *
Moderate SGA Percentiles 6–10
<5 45 (13.9) 26 (8.1) 1 (reference) 1 (reference)
5–9.9 42 (13.0) 47 (14.5) 0.48 (0.25–0.94) * 0.55 (0.26–1.16)
10–19.9 103 (31.9) 95 (29.4) 0.60 (0.34–1.07) 0.59 (0.31–1.12)
20–29.9 85 (26.3) 114 (35.0) 0.41 (0.23–0.74) * 0.41 (0.21–0.78) *
≥30 48 (14.9) 42 (13.0) 0.64 (0.34–1.22) 0.62 (0.31–1.25)
p for trend 0.964 0.868
<5 vs. ≥5 0.53 (0.31–0.89) * 0.53 (0.30–0.96) *
Severe SGA, Percentiles≤5
<5 26 (13.3) 16 (8.2) 1 (reference) 1 (reference)
5–9.9 18 (9.2) 23 (11.8) 0.47 (0.19–1.16) 0.46 (0.17–1.22)
10–19.9 47 (24.1) 64 (32.8) 0.44 (0.20–0.94) * 0.44 (0.19–0.99) *
20–29.9 64 (32.8) 57 (29.2) 0.68 (0.32–1.46) 0.61 (0.26–1.34)
≥30 40 (20.5) 35 (18.0) 0.66 (0.29–1.50) 0.59 (0.24–1.44)
p for trend 0.568 0.853
<5 vs. ≥5 0.55 (0.27–1.10) 0.51 (0.24–1.07)
aOR: Adjusted odds ratio by income, smoking, previous preterm/low birthweight newborn, energy intake,
newborn’s gender, and pre-pregnancy BMI; cOR: Crude odds ratio and confidence intervals (95% CI);
* Significant association.
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In Table 6, the different types of fatty acids (monounsaturated fatty acids (MUFA), polyunsaturated
fatty acids (PUFA) and saturated fats) are analyzed. In our study population a 30% (standard deviation
17%) of MUFA come from OO. No significant differences were observed between cases and controls.
No associations were observed either in the consumption of these fatty acids in isolation and a
protective effect for SGA. No association was found with other fats (soybean oil, sunflower oil, corn oil,
etc.) used for cooking and dressing meals (data not shown).
Women were asked for changes in their diet during pregnancy. A 49.7% of cases increased their
intake of vegetables during pregnancy versus 47.1% of controls (p = 0.401). Regarding fruits both cases
and controls augmented their consumption (61.0% vs. 58.6%, respectively, p = 0.437), and about olive
oil intake no difference was also found (6.8% vs. 7.0%, p = 0.901).
Table 6. Type of fatty acids in quintiles (g/day) and risk of SGA.
Cases n (%) Controls n (%) cOR (95% CI) aOR (95% CI)
MUFA
Q1 (≤37.96 g/day) 99 (19.1) 104 (20.1) 1 (reference) 1 (reference)
Q2 (37.97–43.09) 102 (19.7) 104 (20.1) 1.04 (0.70–1.53) 1.11 (0.73–1.69)
Q3 (43.10–47.18) 99 (19.1) 103 (19.9) 1.01 (0.69–1.49) 1.14 (0.75–1.74)
Q4 (47.19–53.98) 110 (21.2) 104 (20.1) 1.11 (0.49–1.66) 1.12 (0.72–1.73)
Q5 (>53.98) 108 (20.9) 103 (19.9) 1.10 (0.66–1.61) 1.03 (0.69–1.55)
p for trend 0.710 0.731
PUFA
Q1 (≤13.32 g/day) 91 (17.6) 104 (20.1) 1 (reference) 1 (reference)
Q2 (13.33–15.39) 88 (17.0) 104 (20.1) 0.98 (0.65–1.49) 1.03 (0.66–1.60)
Q3 (15.40–17.30) 106 (20.5) 103 (19.9) 1.19 (0.81–1.75) 1.20 (0.79–1.82)
Q4 (17.31–20.12) 116 (21.2) 104 (20.1) 1.31 (0.87–1.96) 1.25 (0.81–1.95)
Q5 (>20.12) 117 (22.6) 103 (19.9) 1.34 (0.88–2.01) 1.19 (0.77–1.84)
p for trend 0.269 0.736
Saturated
Q1 (≤29.90 g/day) 107 (20.7) 104 (20.1) 1 (reference) 1 (reference)
Q2 (29.91–33.80) 99 (19.1) 104 (20.1) 0.91 (0.62–1.35) 0.92 (0.61–1.39)
Q3 (33.81–36.91) 92 (17.8) 103 (19.9) 0.87 (0.59–1.29) 0.91 (0.59–1.41)
Q4 (36.92–40.79) 93 (18.0) 104 (20.1) 0.88 (0.59–1.31) 0.81 (0.53–1.25)
Q5 (>40.79) 127 (24.5) 103 (19.9) 1.21 (0.82–1.79) 1.05 (0.69–1.59)
p for trend 0.067 0.372
aOR: Adjusted odds ratio by income, smoking, previous preterm/low birthweight newborn, energy intake,
newborn’s gender, and pre-pregnancy BMI; cOR: Crude odds ratio and confidence intervals (95% CI); MUFA:
Monounsaturated fatty acids; PUFA: Polyunsaturated fatty acids.
4. Discussion
Our results suggest that maternal adherence to a Mediterranean dietary pattern is associated with
a lower risk of SGA newborn; and mainly for those cases with a moderate degree of disease (percentiles
6–10). This relationship is consistent among the different MD indexes used. It seems that the effect
depends on the diet pattern as a whole, although the role that OO alone may play is significant in itself.
It must be emphasized that no dose-response was observed. According to the several indexes used
after a level of intake no additional benefit was appreciated, and the same occurs with OO.
Fetal life is characterized by tremendous plasticity and the ability to respond to various
environmental and lifestyle factors, including maternal nutrition [37]. In particular, maternal dietary
habits can directly affect newborn weight [20]. Okubo et al. [14], in a cohort study of 803 women
with dietary assessment at the beginning of pregnancy, reported that a diet characterized by a high
consumption of bread, pastry, sweets and soft drinks, and a low consumption of fish and vegetables
is associated with a higher risk of SGA. In contrast, Thompson et al. [16], in a case-control study
(844 SGA and 870 controls) with a FFQ applied after delivery, found that a dietary pattern composed
of meat, potatoes, fruits (particularly citrus fruits), green vegetables, carrots, dairy products and water
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is protective for SGA, aOR = 0.86 (95% CI 0.75–0.99). Similarly, other authors have found a 26%–32%
reduction in the risk of SGA for dietary patterns with a higher intake of fruits, vegetables, poultry and
breakfast cereals [38]. While these studies are not based on a Mediterranean population nor focus on a
MD pattern, the main characteristics of these dietary patterns are very similar to the characteristics of a
higher or lower compliance with a MD. Another Spanish study, based on a small sample (46 SGA and
81 controls) with assessment of diet at the third trimester of pregnancy, has also reported that a MD
pattern is associated with a lower risk of SGA, although the reduction in the risk was not estimated [39].
Regarding OO intake we have found only one report from Northern Italy. In a case-control study
with 555 SGA and 1966 controls Ricci et al reported that a high level of OO intake increased the risk
of SGA [40] with an OR = 1.6 (95% CI, 1.0–2.5), which increased to 3.3 (95% CI, 1.4–7.8) for preterm
SGA. Diet was ascertained after delivery, as in our study. It is not defined in this report what is a
‘high level’ of OO consumption. We have assessed the curve of risk between OO intake in g/day (either
extra virgin or other types) and our results do not agree with theirs. Above 10 g/day the relationship
between OO and SGA risk was flat: No increased risk was found for an intake above 30 g/day, nor for
50 g/day (results not shown). In fact, our results suggest that an OO intake above 10 g/day does add
any further protection.
Our results regarding the severity of SGA cannot be compared with other reports because they
have not defined levels of SGA below the 10th percentile. In some reports, such as that of Ricci et al. [40]
SGA was classified by preterm delivery. The determinants of preterm delivery (92, 17.8%, of our
cases) are different from those of SGA, and mostly not related to intrauterine growth retardation.
We carried out stratified analyses by preterm delivery and not relevant association was detected
(results not shown).
To date, we have not found randomized controlled clinical trials on MD and SGA [41]. Currently,
the evidence available is based on observational studies and residual confounding cannot be ruled out.
However, in Spain a randomized controlled clinical trial with two parallel groups has been developed
with gestational diabetes as the primary outcome: the key intervention group recommendation was
a daily consumption of at least 40 mL of extra virgin OO and a handful (25–30 g) of pistachios,
and the same basic MD recommendations were given to the intervention and control groups [42].
Although it was not the primary outcome, a lower risk of SGA was observed for the intervention
group. Nevertheless, the positive effects on cardiovascular and metabolic health with high compliance
to a MD has been proven [43], and this type of diet could also have a benefit on birth weight, although
evidence from trials is needed.
Our results suggest that the consumption OO of about a spoon a day (about 5 g) is enough to
protect against the risk of SGA. In laboratory studies using mice, Mousavi et al. (2017) reported that a
maternal diet containing extra virgin OO has positive effects on offspring birth weight, as well as better
serum biochemical parameters [44]. OO is a rich source of monounsaturated fatty acids, and has been
found to improve the inflammatory profile [45] as well as to lower postprandial glucose levels [46].
Furthermore, OO is a traditional component of the Spanish cuisine and used as a dressing improves
the palatability of foods and facilitates an increased intake of vegetables. As previously commented,
Assaf-Balut et al. (2017) showed a lower risk for SGA infants in the intervention group with the use of
extra virgin OO and a handful of pistachios [42]. According to our results OO is associated with a lower
risk of SGA, but not MUFA; this may suggest that other components (not type of fat) is responsible of
this protective effect, such as phenols, associated with several chronic diseases [47].
In contrast, the effect of a maternal Mediterranean dietary pattern on birth weight is not observed
for severe SGA (percentiles ≤5). It seems that diet may help in moderate growth retardation but not in
more severe situations, where other causes cannot be counteracted by diet. It could be possible that
the effect of a MD would be maintained in severe SGA but we could not observe it due to: (a) newborn
weight depends on multiple factors; (b) the relevance of each factor is related to its frequency and the
frequency of the other factors; (c) the presence of other causes, mainly maternal pathology related
to chronic diseases or associated to pregnancy, reduces the role of MD on fetal development; (d) an
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interaction between dietary pattern and pathologies cannot be discarded; and (e) the study power is
not enough. New studies are needed to overcome these limitations.
5. Strengths and Limitations
The strengths of our study are: (1) the sample is representative of a reference population of around
12,000 healthy pregnant women attending Spanish Andalusian public hospitals; (2) we used established
Spanish fetal growth curves to define adequate size for gestational age [22]; (3) we employed a FFQ
validated in the Spanish population [26,27]; (4) the control group was selected by density in the same
hospitals as cases to avoid seasonal influences on diet recording.
We also have to recognize some limitations: (1) all questionnaires were recorded after birth
but before hospital discharge, with the intention of estimating the average dietary intake during
pregnancy. However, delivery and the last gestational week of pregnancy would be unlikely to
change their habitual gestational dietary patterns. We assessed the change of diet during pregnancy
and the differences between cases in controls were minimal (1%–2% better for cases); a differential
misclassification bias cannot be rule out altogether, although given the reported data, its impact on
the reported OR figures would not change appreciably; (2) the information was taken by midwives,
possibly introducing a classification bias as the participating women may want to respond with
answers they believe will please the midwife: a bias that would affect both groups and shift the size of
the association strength toward the null value; (3) we cannot discard a memory bias, but if present,
we think it would be a non-differential bias as no relationship between a particular food intake and
SGA is assumed beforehand; (4) given the nature of observational studies, ours results cannot be free
of residual confounding; (5) the problem of multiple comparisons: it could be possible that some
associations may be appeared by chance; however, regarding the main point of the research, MD has
been ascertained by three indexes and the results are consistent; and (6) the cutoff points for the MD
scales and OO intake were chosen after examining the data, once that we did not appreciate any
dose-response trend.
6. Conclusions
In conclusion, our results suggest that adherence to a MD pattern during pregnancy is associated
with a reduced risk of having a baby with SGA, independently of the index used. This relationship
was particularly evident in pregnant women who had moderate SGA (percentiles 6–10). Consumption
of at least 5 g/day of OO is also associated with a lower risk of SGA. Bearing in mind the benefits of a
Mediterranean diet on maternal, fetal and offspring health, it should be promoted before, during and
after pregnancy.
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